Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
New York, New York--(Newsfile Corp. - June 15, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Ch
Los Angeles, California--(Newsfile Corp. - June 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (
San Francisco, California--(Newsfile Corp. - June 14, 2021) -  Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud cl
New York, New York--(Newsfile Corp. - June 14, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased ChemoCentryx, Inc.
New York, New York--(Newsfile Corp. - June 14, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ChemoCentryx, Inc. (NASDAQ: CCXI) alleging
New York, New York--(Newsfile Corp. - June 13, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Ch
New York, New York--(Newsfile Corp. - June 12, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investo
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CCXI--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc.
LOS ANGELES, June 11, 2021 /PRNewswire/ --  Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming  July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on
New York, New York--(Newsfile Corp. - June 11, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between Novembe
RADNOR, Pa., June 11, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ:  CCXI) ("ChemoCentryx") investors that a securities fraud class acti
ChemoCentryx (CCXI) stock is on the rise Friday as investors anticipate one of its treatments getting approval from the FDA. The post CCXI Stock: 12 Things to Know About ChemoCentryx as Shares Surge T
Los Angeles, California--(Newsfile Corp. - June 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (
New York, New York--(Newsfile Corp. - June 11, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ChemoCentryx, Inc. (NASDAQ: CCXI) alleging
NEW YORK, June 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI).   Such investors are ad
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE